#NewsWatch: FDA panel recommends Pfizer’s COVID-19 booster for 65 and older, but not for the general public

“#NewsWatch: FDA panel recommends Pfizer’s COVID-19 booster for 65 and older, but not for the general public”
A group of advisors to the Food and Drug Administration on Friday reframed a proposed approval of BioNTech and Pfizer’s COVID-19 booster for the general population, and it instead recommended authorization of an additional dose of the vaccine to people at least 65 years old and those at high risk for severe disease.

If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on the star and choose us from your favorites.

For forums sites go to Forum.BuradaBiliyorum.Com

If you want to read more News articles, you can visit our News category.

Source